Intrinsiqs

Is Anixa Biosciences, Inc. overvalued?

Anixa Biosciences, Inc. (ANIX) — key valuation metrics and fundamentals.

No verdict
Price
$3.18
Fair value
Current P/E
Normal P/E
Market cap
$108.2M
Dividend yield
0.0%
Return on equity
-65.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ANIX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.